Down-regulation of annexin II in prostate cancer is associated with Gleason score, recurrence, metastasis and poor prognosis

Molecular Medicine Reports

Volumn 3, Issue 5, 2010, Pages 781-787

  Ding, Tao ^a,b   Yang, Luoyan ^a   Wang, Yinhuai ^a   Yuan, Junbin ^a   Chen, Tieding ^a   Cai, Xiaojian ^b  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b UNIVERSITY OF SOUTH CHINA   (China)

Author keywords

Annexin II; Gleason scores; Prognosis; Prostate cancer

Indexed keywords

LIPOCORTIN 2;

ADULT; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CELL INVASION; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISTANT METASTASIS; DOWN REGULATION; GLEASON SCORE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; METASTASIS; OVERALL SURVIVAL; PROGNOSIS; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROTEIN EXPRESSION;

EID: 78049491901     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2010.332     Document Type: Article

References (26)

1. Ang EZ, Nguyen HT, Sim HL, Putti TC and Lim LH: Annexin-1 regulates growth arrest induced by high levels of estrogen in MCF-7 breast cancer cells. Mol Cancer Res 7: 266-274, 2009.
2. Mussunoor S and Murray GI: The role of annexins in tumour development and progression. J Pathol 216: 131-140, 2008.
3. Nakahara S and Raz A: Biological modulation by lectins and their ligands in tumorprogression and metastasis. Anticancer Agents Med Chem 8: 22-36, 2008. (Pubitemid 351445058)
4. Zhang F, Zhang L, Zhang B, Wei X, Yang Y, Qi RZ, Ying G, Zhang N and Niu R: Anxa2 plays a critical role in enhanced invasiveness of the multidrug resistant human breast cancer cells. J Proteome Res 8: 5041-5047, 2009.
5. Bao H, Jiang M, Zhu M, Sheng F, Ruan J and Ruan C: Overexpression of Annexin II affects the proliferation, apoptosis, invasion and production of proangiogenic factors in multiple myeloma. Int J Hematol 90: 177-185, 2009.
6. Inokuchi J, Lau A, Tyson DR and Ornstein DK: Loss of annexin A1 disrupts normal prostate glandular structure by inducing autocrine IL-6 signaling. Carcinogenesis 30: 1082-1098, 2009.
7. Liu J and Vishwanatha JK: Regulation of nucleo-cytoplasmic shuttling of human annexin A2: a proposed mechanism. Mol Cell Biochem 303: 211-220, 2007. (Pubitemid 47261319)
8. Inokuchi J, Narula N, Yee DS, Skarecky DW, Lau A, Ornstein DK and Tyson DR: Annexin A2 positively contributes to the malignant phenotype and secretion of IL-6 in DU145 prostate cancer cells. Int J Cancer 124: 68-74, 2009.
9. Kido O, Fukushima K, Ueno Y, Inoue J, Jefferson DM and Shimosegawa T: Compensatory role of inducible annexin A2 for impaired biliary epithelial anion-exchange activity of inflammatory cholangiopathy. Lab Invest 89: 1374-1386, 2009.
10. Nedjadi T, Kitteringham N, Campbell F, Jenkins RE, Park BK, Navarro P, Ashcroft F, Tepikin A, Neoptolemos JP and Costello E: S100A6 binds to annexin 2 in pancreatic cancer cells and promotes pancreatic cancer cell motility. Br J Cancer 101: 1145-1154, 2009.
11. Grewal T and Enrich C: Annexins - modulators of EGF receptor signalling and trafficking. Cell Signal 21: 847-858, 2009.
12. Ji NY, Park MY, Kang YH, Lee CI, Kim DG, Yeom YI, Jang YJ, Myung PK, Kim JW, Lee HG, Kim JW, Lee K and Song EY: Evaluation of annexin II as a potential serum marker for hepatocellular carcinoma using a developed sandwich ELISA method. Int J Mol Med 24: 765-771, 2009.
13. Mohammad HS, Kurokohchi K, Yoneyama H, et al: Annexin A2 expression and phosphorylation are up-regulated in hepatocellular carcinoma. Int J Oncol 33: 1157-1163, 2008.
14. Huang Y, Jin Y, Yan CH, Yu Y, Bai J, Chen F, Zhao YZ and Fu SB: Involvement of Annexin A2 in p53 induced apoptosis in lung cancer. Mol Cell Biochem 309: 117-123, 2008.
15. Park MH, Cho SA, Yoo KH, Yang MH, Ahn JY, Lee HS, Lee KE, Mun YC, Cho DH, Seong CM and Park JH: Gene expression profile related to prognosis of acute myeloid leukemia. Oncol Rep 18: 1395-1402, 2007.
16. Rodrigo Tapia JP, Pena Alonso E, García-Pedrero JM, Florentino Fresno M, Suárez Nieto C, Owen Morgan R and Fernández MP: Annexin A2 expression in head and neck squamous cell carcinoma. Acta Otorrinolaringol Esp 58: 257-262, 2007.
17. Ellinger J, Bastian PJ, Jurgan T, Biermann K, Kahl P, Heukamp LC, Wernert N, Müller SC and von Ruecker A: CpG island hypermethylation at multiple gene sites in diagnosis and prognosis of prostate cancer. Urology 71: 161-167, 2008. (Pubitemid 351173282)
18. Banerjee AG, Liu J, Yuan Y, Gopalakrishnan VK, Johansson SL, Dinda AK, Gupta NP, Trevino L and Vishwanatha JK: Expression of biomarkers modulating prostate cancer angiogenesis: differential expression of annexin II in prostate carcinomas from India and USA. Mol Cancer 2: 34, 2003.
19. Yee DS, Narula N, Ramzy I, Boker J, Ahlering TE, Skarecky DW and Ornstein DK: Reduced annexin II protein expression in high-grade prostatic intraepithelial neoplasia and prostate cancer. Arch Pathol Lab Med 131: 902-908, 2007. (Pubitemid 46906381)
20. Zimmermann U, Woenckhaus C, Pietschmann S, Junker H, Maile S, Schultz K, Protzel C and Giebel J: Expression of annexin II in conventional renal cell carcinoma is correlated with Fuhrman grade and clinical outcome. Virchows Arch 445: 368-374, 2004.
21. Reeves SA, Chavez-Kappel C, Davis R, Rosenblum M and Israel MA: Developmental regulation of annexin II (lipocortin 2) in human brain and expression in high grade glioma. Cancer Res 52: 6871-6876, 1992. (Pubitemid 23006292)
22. Diaz VM, Hurtado M, Thomson TM, Reventos J and Paciucci R: Specific interaction of tissue-type plasminogen activator (t-PA) with annexin II on the membrane of pancreatic cancer cells activates plasminogen and promotes invasion in vitro. Gut 53: 993-1000, 2004. (Pubitemid 38824158)
23. Paciucci R, Tora M, Diaz VM and Real FX: The plasminogen activator system in pancreas cancer: role of t-PA in the invasive potential in vitro. Oncogene 16: 625-633, 1998. (Pubitemid 28062342)
24. Aguilar S, Corominas JM, Malats N, Pereira JA, Dufresne M, Real FX and Navarro P: Tissue plasminogen activator in murine exocrine pancreas cancer. Am J Pathol 165: 1129-1139, 2004.
25. Mai J, Waisman DM and Sloane BR: Cell surface complex of cathepsin B/annexin II tetramer in malignant progression. Biochem Biophys Acta 1477: 215-230, 2000.
26. Shiozawa Y, Havens AM, Jung Y, Ziegler AM, Pedersen EA, Wang J, Wang J, Lu G, Roodman GD, Loberg RD, Pienta KJ and Taichman RS: Annexin II/annexin II receptor axis regulates adhesion, migration, homing, and growth of prostate cancer. J Cell Biochem 105: 370-380, 2008.